CAS No. 96946-42-8
| IUPAC Name | benzenesulfonate;5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate | |
|---|---|---|
| CAS Number | 96946-42-8 | |
| Molecular Formula |
C53H72N2O12.2C6H5O3S |
|
| Molecular Weight (MW) | 1243.48 | |
| SMILES | C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-] | |
| InChIKey | XXZSQOVSEBAPGS-DONVQRBFSA-L |
Cisatracurium besylate is a nondepolarizing neuromuscular blocking agent that acts as a competitive antagonist of nicotinic acetylcholine receptors at the neuromuscular junction. By selectively binding to post-junctional nicotinic acetylcholine receptors, it competitively blocks acetylcholine binding and prevents end-plate depolarization. This inhibition of neuromuscular transmission suppresses action potential propagation along muscle membranes, resulting in effective blockade of skeletal muscle contraction. [1]
| Solvent | Solubility & Note |
|---|---|
| DMSO |
100 mg/mL
(80.41 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | 100 mg/mL |
| Ethanol | 100 mg/mL |
| DMSO |
100 mg/mL
(80.41 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | 100 mg/mL |
| Ethanol | 100 mg/mL |
| DMSO |
249 mg/mL
(200.24 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 249 mg/mL |
| Water | 47 mg/mL |
| DMSO |
100 mg/mL
(80.41 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 100 mg/mL |
| Water | 50 mg/mL |
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Pre-aliquoted for Longevity: Solid-state aliquots offer significantly longer shelf life compared to stock solutions, ensuring maximum stability for every use.
Looking for a specific aliquot size? Reach out to your local sales representative or contact us at orders@selleckchem.com.
- Cisatracurium Besylate Clinical Trials
- Cisatracurium Besylate Solubility in DMSO
- Cisatracurium Besylate Storage
- Cisatracurium Besylate Stability
- Cisatracurium Besylate Molecular Weight
- Cisatracurium Besylate SMILES
- Cisatracurium Besylate Chemical Structure (2D and 3D)
- Cisatracurium Besylate SDS|MSDS